MedPath

Effect of Conjugated Linoleic Acid on Body Fat in Overweight Children

Not Applicable
Completed
Conditions
Overweight
Interventions
Dietary Supplement: Conjugated linoleic acid
Registration Number
NCT00575991
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The prevalence of overweight children has increased dramatically over the last decade, and many overweight children will remain overweight as adults. Conjugated linoleic acid (CLA), a naturally occurring dietary fatty acid, has shown promising results in reducing body fat among adults, and we propose to test the efficacy of CLA supplementation on body fat accretion in 6 to 10 year old children who are overweight or at risk of overweight.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • age 6 to 10 years
  • body mass index greater than 85th percentile
  • Tanner stage I
Exclusion Criteria
  • medical condition
  • dairy allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AConjugated linoleic acid-
BConjugated linoleic acid-
Primary Outcome Measures
NameTimeMethod
body composition using DXA6 months
Secondary Outcome Measures
NameTimeMethod
blood chemistry variables including fasting glucose and insulin, lipids, and liver enzymes6 months

Trial Locations

Locations (1)

University of Wisconsin Department of Nutritional Sciences

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath